Advaxis (ADXSD)

Advaxis (ADXSD) Stock Price & Analysis


ADXSD Stock Chart & Stats

Day’s Range$3.3 - $3.85
52-Week Range$0.06 - $5.00
Previous Close$3.85
Average Volume (3M)388.08K
Market Cap
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)N/A
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-6.92
Shares Outstanding1,820,480
10 Day Avg. Volume180,297
30 Day Avg. Volume401,574
Standard Deviation0.32
Financial Highlights & Ratios
Price to Book (P/B)0.16
Price to Sales (P/S)18.24
Price to Cash Flow (P/CF)N/A
P/FCF Ratio-0.50
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0



Risk Analysis

Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products

Product Insights

Sorry, No Data Available
There is no website visitor data available for this stock.



What was Advaxis’s price range in the past 12 months?
Advaxis lowest stock price was $0.06 and its highest was $5.00 in the past 12 months.
    What is Advaxis’s market cap?
    Currently, no data Available
    When is Advaxis’s upcoming earnings report date?
    The company’s upcoming earnings report date is not yet available.
    How were Advaxis’s earnings last quarter?
    Currently, no data Available
    Is Advaxis overvalued?
    According to Wall Street analysts Advaxis’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
      Does Advaxis pay dividends?
      Advaxis does not currently pay dividends.
      What is Advaxis’s EPS estimate?
      Advaxis’s EPS estimate for its next earnings report is not yet available.
      How many shares outstanding does Advaxis have?
      Currently, no data Available
      What happened to Advaxis’s price movement after its last earnings report?
      Currently, no data Available
      Which hedge fund is a major shareholder of Advaxis?
      Currently, no hedge funds are holding shares in ADXSD


      Advaxis Stock Smart Score

      This stock does not have enough of the key information we need to rate it accurately. Smart Score is calculated for stocks traded in Nasdaq, NYSE, TSE and LSE with a market cap above $30M and average 3 months trading volume above $30K.
      Learn more about TipRanks Smart Score

      Company Description


      Advaxis, Inc. is a biotechnology company, which engages in the discovery, development and commercialization of cancer immunotherapies. It manages platform technology that utilizes live attenuated Listeria monocytogenes bioengineered to secrete antigen or adjuvant fusion proteins. It has four franchises in various stages of clinical and pre-clinical development, namely: HPV-associated cancers, prostate cancer, neoantigen therapy and hotspot mutation therapy. The company was founded on June 5, 1987 and is headquartered in Princeton, NJ.


      Forecast EPS vs Actual EPS

      Currently, no data available
      Please return soon. This page is being updated.

      Similar Stocks
      Price & Change
      Chinook Therapeutics
      Inovio Pharmaceuticals
      Merck & Company

      Popular Stocks

      What's Included in PREMIUM?
      Make informed decisions based on Top Analysts' activity
      Know what industry insiders are buying
      Get actionable alerts from top Wall Street Analysts
      Find out before anyone else which stock is going to shoot up
      Get powerful stock screeners & detailed portfolio analysis